دورية أكاديمية
Aptamer-mediated hollow MnO2 for targeting the delivery of sorafenib
| العنوان: | Aptamer-mediated hollow MnO2 for targeting the delivery of sorafenib |
|---|---|
| المؤلفون: | Ziyue Wang, Cuicui Wu, Jinren Liu, Shunxin Hu, Junli Yu, Qiangqiamg Yin, Hongda Tian, Zhipeng Ding, Guiqiang Qi, Li Wang, Liguo Hao |
| المصدر: | Drug Delivery, Vol 30, Iss 1, Pp 28-39 (2023) |
| بيانات النشر: | Taylor & Francis Group, 2023. |
| سنة النشر: | 2023 |
| المجموعة: | LCC:Therapeutics. Pharmacology |
| مصطلحات موضوعية: | Hollow mesoporous MnO2, drug delivery system, HCC, MR imaging, Therapeutics. Pharmacology, RM1-950 |
| الوصف: | AbstractSorafenib (SRF) presents undesirable effects in clinical treatment, due to the lack of targeting, poor water solubility, and obvious side effects. In this study, we constructed a novel nanodrug carrier system for accurate and efficient delivery of SRF, improving its therapeutic effects and achieving tumor-specific imaging. The hollow mesoporous MnO2 (H-MnO2) nanoparticles equipped with target substance aptamers (APT) on the surface were used to load SRF for the first time. The resulting H-MnO2-SRF-APT could specifically bound to glypican-3 (GPC3) receptors on the surface of hepatocellular carcinoma (HCC), rapidly undergoing subsequent degradation under decreased pH conditions in the tumor microenvironment (TME) and releasing the loaded SRF. In this process, Mn2+ ions were used for T1-weighted magnetic resonance imaging simultaneously. The in vitro cell experiments indicated that H-MnO2-SRF-APT showed much more effects on the inhibition in the proliferation of Huh7 and HepG2 HCC cells than that of the non-targeted H-MnO2-SRF and free SRF. Besides, the in vivo results further confirmed that H-MnO2-SRF-APT could effectively inhibit the growth of xenograft tumors Huh7 in the naked mouse with good biosafety. In conclusion, H-MnO2-SRF-APT could significantly enhance the therapeutic effect of SRF and is expected to be a new way of diagnosis and treatment of HCC. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 10717544 1521-0464 1071-7544 |
| العلاقة: | https://doaj.org/toc/1071-7544Test; https://doaj.org/toc/1521-0464Test |
| DOI: | 10.1080/10717544.2022.2149897 |
| الوصول الحر: | https://doaj.org/article/5d70968094b2475a8e76863b637545d2Test |
| رقم الانضمام: | edsdoj.5d70968094b2475a8e76863b637545d2 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | ResultId |
1 |
|---|---|
| Header |
edsdoj Directory of Open Access Journals edsdoj.5d70968094b2475a8e76863b637545d2 1046 3 Academic Journal academicJournal 1045.96520996094 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.5d70968094b2475a8e76863b637545d2&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doaj.org/article/5d70968094b2475a8e76863b637545d2 [Name] => EDS - DOAJ [Category] => fullText [Text] => View record in DOAJ [MouseOverText] => View record in DOAJ ) [1] => Array ( [Url] => https://resolver.ebscohost.com/openurl?custid=s6537998&groupid=main&authtype=ip,guest&sid=EBSCO:edsdoj&genre=article&issn=10717544&ISBN=&volume=30&issue=1&date=20231201&spage=28&pages=28-39&title=Drug Delivery&atitle=Aptamer-mediated%20hollow%20MnO2%20for%20targeting%20the%20delivery%20of%20sorafenib&id=DOI:10.1080/10717544.2022.2149897 [Name] => Full Text Finder (s6537998api) [Category] => fullText [Text] => Full Text Finder [Icon] => https://imageserver.ebscohost.com/branding/images/FTF.gif [MouseOverText] => Full Text Finder ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Aptamer-mediated hollow MnO2 for targeting the delivery of sorafenib
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Ziyue+Wang%22">Ziyue Wang</searchLink><br /><searchLink fieldCode="AR" term="%22Cuicui+Wu%22">Cuicui Wu</searchLink><br /><searchLink fieldCode="AR" term="%22Jinren+Liu%22">Jinren Liu</searchLink><br /><searchLink fieldCode="AR" term="%22Shunxin+Hu%22">Shunxin Hu</searchLink><br /><searchLink fieldCode="AR" term="%22Junli+Yu%22">Junli Yu</searchLink><br /><searchLink fieldCode="AR" term="%22Qiangqiamg+Yin%22">Qiangqiamg Yin</searchLink><br /><searchLink fieldCode="AR" term="%22Hongda+Tian%22">Hongda Tian</searchLink><br /><searchLink fieldCode="AR" term="%22Zhipeng+Ding%22">Zhipeng Ding</searchLink><br /><searchLink fieldCode="AR" term="%22Guiqiang+Qi%22">Guiqiang Qi</searchLink><br /><searchLink fieldCode="AR" term="%22Li+Wang%22">Li Wang</searchLink><br /><searchLink fieldCode="AR" term="%22Liguo+Hao%22">Liguo Hao</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Drug Delivery, Vol 30, Iss 1, Pp 28-39 (2023) ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Taylor & Francis Group, 2023. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2023 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => LCC:Therapeutics. Pharmacology ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Hollow+mesoporous+MnO2%22">Hollow mesoporous MnO2</searchLink><br /><searchLink fieldCode="DE" term="%22drug+delivery+system%22">drug delivery system</searchLink><br /><searchLink fieldCode="DE" term="%22HCC%22">HCC</searchLink><br /><searchLink fieldCode="DE" term="%22MR+imaging%22">MR imaging</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%2E+Pharmacology%22">Therapeutics. Pharmacology</searchLink><br /><searchLink fieldCode="DE" term="%22RM1-950%22">RM1-950</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => AbstractSorafenib (SRF) presents undesirable effects in clinical treatment, due to the lack of targeting, poor water solubility, and obvious side effects. In this study, we constructed a novel nanodrug carrier system for accurate and efficient delivery of SRF, improving its therapeutic effects and achieving tumor-specific imaging. The hollow mesoporous MnO2 (H-MnO2) nanoparticles equipped with target substance aptamers (APT) on the surface were used to load SRF for the first time. The resulting H-MnO2-SRF-APT could specifically bound to glypican-3 (GPC3) receptors on the surface of hepatocellular carcinoma (HCC), rapidly undergoing subsequent degradation under decreased pH conditions in the tumor microenvironment (TME) and releasing the loaded SRF. In this process, Mn2+ ions were used for T1-weighted magnetic resonance imaging simultaneously. The in vitro cell experiments indicated that H-MnO2-SRF-APT showed much more effects on the inhibition in the proliferation of Huh7 and HepG2 HCC cells than that of the non-targeted H-MnO2-SRF and free SRF. Besides, the in vivo results further confirmed that H-MnO2-SRF-APT could effectively inhibit the growth of xenograft tumors Huh7 in the naked mouse with good biosafety. In conclusion, H-MnO2-SRF-APT could significantly enhance the therapeutic effect of SRF and is expected to be a new way of diagnosis and treatment of HCC. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article ) Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => electronic resource ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 10717544<br />1521-0464<br />1071-7544 ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => https://doaj.org/toc/1071-7544; https://doaj.org/toc/1521-0464 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1080/10717544.2022.2149897 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://doaj.org/article/5d70968094b2475a8e76863b637545d2" linkWindow="_blank">https://doaj.org/article/5d70968094b2475a8e76863b637545d2</link> ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsdoj.5d70968094b2475a8e76863b637545d2 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1080/10717544.2022.2149897
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 12
[StartPage] => 28
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Hollow mesoporous MnO2
[Type] => general
)
[1] => Array
(
[SubjectFull] => drug delivery system
[Type] => general
)
[2] => Array
(
[SubjectFull] => HCC
[Type] => general
)
[3] => Array
(
[SubjectFull] => MR imaging
[Type] => general
)
[4] => Array
(
[SubjectFull] => Therapeutics. Pharmacology
[Type] => general
)
[5] => Array
(
[SubjectFull] => RM1-950
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Aptamer-mediated hollow MnO2 for targeting the delivery of sorafenib
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ziyue Wang
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Cuicui Wu
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jinren Liu
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Shunxin Hu
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Junli Yu
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Qiangqiamg Yin
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Hongda Tian
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Zhipeng Ding
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Guiqiang Qi
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Li Wang
)
)
)
[10] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Liguo Hao
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 12
[Type] => published
[Y] => 2023
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 10717544
)
[1] => Array
(
[Type] => issn-print
[Value] => 15210464
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 30
)
[1] => Array
(
[Type] => issue
[Value] => 1
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Drug Delivery
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |